Pancreatic Cancer: Research-driven Clinical Progress Examined at AACR Special Conference
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
Category: Meetings
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
In the opening keynote session of the AACR Special Conference on Pancreatic Cancer, which took place September 27-30 in...
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...
AACR is a pioneer in the study of racial/ethnic and other disparities in cancer research and care. The 16th...
Centuries ago, when several Native tribes in northeastern America were at constant war, a peacemaker came to stop the...
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
Renowned prostate cancer researcher Folakemi T. Odedina, PhD, took the stage at the AACR Conference on the Science of...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...